PRODUCT TRANSFER.

Slides:



Advertisements
Similar presentations
Basic Principles of GMP
Advertisements

Project Quality Plans Gillian Sandilands Director of Quality
Course Material Overview of Process Safety Compliance with Standards
Annual Product Review (APR) Product Quality Review (PQR)
Ensure Vendor/Engineer of Choice Product Quality
Module 6 | Slide 1 of Contract Production, Analysis and other activities Section 7 Basic Principles of GMP.
Reprocessing Biotech Products
Good Manufacturing Practices Guilin, PRC Dr AJ van Zyl for Quality Assurance and Safety: Medicines Medicines Policy and Standards Health Technology and.
Batch Reworking and Reprocessing
Integrating CMC Review & Inspection Industry Recommendations Joe Anisko April 24, 2003.
Managing the Information Technology Resource Jerry N. Luftman
Pertemuan Matakuliah: A0214/Audit Sistem Informasi Tahun: 2007.
Slide 1 of 19D.K. Mubangizi, Dar Es Salaam Sept Training Workshop for Evaluators from National Medicines Regulatory Authorities in East African Community.
MANUFACTURING OF API AND INTERMEDIATES
Reference, Retention and Reserve Samples
Roles and Responsibilities
Management of Change Control. Overview Changes – Good or bad? Forced or voluntary? The Importance of Change Control Major Changes to both legacy company.
1 GMP issues in Q assessment Wondiyfraw Worku Assessor 6 th CPH assessment training workshop, May 2014.
World Health Organization
WHO Supplementary Training Modules GMP
Top Tactics for Maximizing GMP Compliance in Blue Mountain RAM Jake Jacanin, Regional Sales Manager September 18, 2013.
Project Life Cycle Introduction and Overview © Ed Green Penn State University All Rights Reserved.
Radiopharmaceutical Production
Healing Hands Clinical Research Services is a Site Management organization with broad spectrum of activities.
Project Management An Overview John Mulhall MIICM; LIB International Credit & Process Management Professional.
Executive summary prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY RISK MANAGEMENT.
World Health Organization
S/W Project Management
Technology Transfer & Quality
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
World Health Organization
1 Supplements and Other Changes to an Approved Application By: Richard J. Stec Jr., Ph.D. February 7, 2007.
Railway Transport Equipment (RTE) Certification Railway Transport Equipment Certification Procedure Application for railway transport equipment certification.
© Pharmaceutical Consultancy Services, All rights reserved. Quality System(s)
Next Doc Project Team: xxxxx Spring TitlePage Scope Statement Mission Statement3 Business Need4 Project Description5-6 Project Lifecycle Approach7.
Module 1, Part 3: Process validation Slide 1 of 22 © WHO – EDM – 12/2001 Validation Part 3: Process validation Supplementary Training Modules on Good Manufacturing.
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. THE PRACTICE OF REGULATORY INTELLIGENCE: CASE STUDIES OMICS 5 th International Pharmaceutical.
© 2006 Cisco Systems, Inc. All rights reserved.Cisco Public 1 Version 4.0 Gathering Network Requirements Designing and Supporting Computer Networks – Chapter.
Important informations
Module 6 | Slide 1 of Contract Production and Analysis Section 7 Basic Principles of GMP.
Good Practices in Production and Quality Control Related Guidelines
© 2006 Cisco Systems, Inc. All rights reserved.Cisco Public 1 Version 4.0 Gathering Network Requirements Designing and Supporting Computer Networks – Chapter.
Molecule-to-Market-Place Quality
Development and Approval of Drugs and Devices EPI260 Lecture 6: Late Phase Clinical Trials April 28, 2011 Richard Chin, M.D.
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
Validation | Slide 1 of 27 August 2006 Validation Supplementary Training Modules on Good Manufacturing Practice WHO Technical Report Series, No. 937, 2006.
IAEA International Atomic Energy Agency Methodology and Responsibilities for Periodic Safety Review for Research Reactors William Kennedy Research Reactor.
SOLUTION What kind of plan do we need? How will we know if the work is on track to be done? How quickly can we get this done? How long will this work take.
Validation Validation: A systematic study which ensures that systems, facilities and processes are working adequetly and precisely. Validation is an integral.
General Aspects of Quality assessment of multisource interchangeable medicines Rutendo Kuwana Technical Officer, WHO, Geneva Training workshop: Assessment.
Development through partnership Infrastructure Delivery Management Toolkit: 2010 Edition Delivery Process 2: Project Management 1.
Module 2Slide 1 of 26 WHO - EDM Quality Management Basic Principles of GMP Part One.
1 A Seminar On Pharmaceutical Outsourcing A Seminar On Pharmaceutical Outsourcing.
Pharmaceutical Quality Control & current Good Manufacturing Practice
© Pharmaceutical Consultancy Services, All rights reserved. Quality System(s) Jaap Koster.
CM&C Inspections The Pre-Approval Inspection (PAI) in the US 27 May 2010.
LECTURE 5 Nangwonvuma M/ Byansi D. Components, interfaces and integration Infrastructure, Middleware and Platforms Techniques – Data warehouses, extending.
Responsibilities of Sponsor, Investigator and Monitor
ANNUAL PRODUCT REVIEW Patchara Kootiratrakarn Independent consultant.
GOOD MANUFACTURING PRACTICE FOR BIOPROCESS ENGINEERING (ERT 425)
Responsibilities of Sponsor, Investigator and Monitor
Pharmaceutical Quality Control & current Good Manufacturing Practice
CHANGE CONTROL.
Author: Nurul Azyyati Sabri
Quality Assurance and Quality Control in Generics
Technology Transfer / Consent Decree Remediation
Lesson 5: BRITE Seminar: GMP II
Quality Management Systems – Requirements
PSS verification and validation
Computer System Validation
Presentation transcript:

PRODUCT TRANSFER

Scope This scope applies to all Product transfers of marketed : Active Pharmaceutical Ingredient Intermediate Pharmaceutical product Medical Device From : one site to another site within the same company one site to an external sub-contractor or visa versa Between two sub-contractors This scope does not apply to transfers of new products from Development to commercial manufacturing

Responsibilities Operational Sourcing Committee : propose, review, approve transfers Project leader : solution of transfer-related issues, preparation of transfer protocol, communication with sites and operational management Site project coordinator : at sending and receiving sites, focal point for communication, ensure coordination and oversight within their site, can be project leader

Responsibilities Cross-functional transfer team (representatives from involved functions at sending and receiving sites) : performing activities associated with transfer : manufacturing and control processes Quality at originating site assess compliance status of receiving site / feasibility study Regulatory at both sites: define regulatory strategy with Quality CMC

Responsibilities Regulatory at sending site: assess receiving site is authorised by Regulatory Authorities for Manufacture and testing of concerned API or pharmaceutical form Site quality management : sending and receiving site review and approve transfer protocol and report Receiving site review and approve validation protocol Quality function has final responsibility to accept or reject transfers

Responsibilities Sending site : supply product to market until final approval from receiving site : avoid stock-out!

Requirements Transfer must ensure maintenance of: Product quality Process robustness Regulatory compliance

Requirements Transfer Process Phases 1 - Pre-evaluation Originates in company Operational Unit transfer request form describing the product is issued Regulatory at sending site performs compliance assessment of product in all markets 2 - Feasibility Study Transfer request form Sending and Receiving sites determine means and timelines

Requirements Feasibility Study outcomes are : Definition of objectives and organization Appointment of transfer team leader, coordinators at S & R sites, cross-functional transfer team Quality and compliance assessment of receiving unit : company own site or subcontractor with audit result. For subcontractor: in case no audit available perform GMP audit. If critical findings : raise CAPA prior to starting operational transfer phase Regulatory evaluation : regulatory strategy defined (cf. slide 4 for responsibilities)

Requirements Feasibility Study outcomes are (cont.) : Product stability evaluation assessed by sending site based on post-approval study results Technical feasibility evaluation : » sending site creates transfer dossier with technical details » existing documents available to receiving site » receiving site assess technical feasibility : process and product » if changes needed : pilot or industrial trials to be performed and evaluation of impact » major change required (development/new process) outside of this scope » complete study documented

Requirements 3 - Transfer Protocol Defined and based on feasibility study results All activities, associated responsibilities and timelines described Stability protocol and Regulatory strategy/actions included APIs : protocol must include strategy how to include new manufacturing site in all dossiers and necessary stability studies of medicinal products or medical device Stability protocol : validation batches with 3 months stability results assessment before receiving site batches release Accelerated conditions or extended post-approval study in case of stability sensitive product Zones III/IV markets : stability study to be considered Transportation stability study to be considered Protocol reviewed and approved (cf. slide 4)

Requirements 4 – Operational Phase Responsibility : Receiving Site Analytical transfer : before process transfer Preparation of Process validation : Review of process validation performed in SS by the RS Quality assessment based on APR or separate risk analysis Production of pilot or industrial batches at RS Orders of required materials, components, equipments Installation of required qualification of equipments, utilities and facilities. Any change change control ; equipment transferred to be requalified prior to use RS Staff trained and documented on all aspects of transfer process

Requirements Preparation of Process validation (cont.) New product introduced in cleaning validation plan at RS Process validation Performed by RS according to validation protocol Manufacture 3 consecutive batches at least Representative of SS can be requested Validation performed when all validation protocol requirements are met and RS quality management approves report Regulatory Activities prepares documents for variations Review and submission : same process as usual In case Pre-AI, submission after review and approval by Quality Other submissions after review and approval by Site Quality Head

Requirements 5 – Finalisation of Product Transfer Product Leader compiles all results in report Assesses the overall success of transfer In-case of development report : included in transfer report SS and RS Quality Heads review and approve product transfer report Regulatory approvals must be obtained before project is considered completed

Requirements 6 – Batch Release Batches released to market Approval from Regulatory Authorities obtained Validation successfully executed and reported All products specifications are met including stability data Release decision : RS Quality Head

Thank You Any Questions